JP2006508178A - 抗菌性ピラゾールカルボン酸ヒドラジド - Google Patents

抗菌性ピラゾールカルボン酸ヒドラジド Download PDF

Info

Publication number
JP2006508178A
JP2006508178A JP2004571158A JP2004571158A JP2006508178A JP 2006508178 A JP2006508178 A JP 2006508178A JP 2004571158 A JP2004571158 A JP 2004571158A JP 2004571158 A JP2004571158 A JP 2004571158A JP 2006508178 A JP2006508178 A JP 2006508178A
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
alkyl
group
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004571158A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006508178A5 (cg-RX-API-DMAC10.html
Inventor
バトラー,マイケル,エム.
Original Assignee
マイクロバイオティクス,インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マイクロバイオティクス,インコーポレーテッド filed Critical マイクロバイオティクス,インコーポレーテッド
Publication of JP2006508178A publication Critical patent/JP2006508178A/ja
Publication of JP2006508178A5 publication Critical patent/JP2006508178A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2004571158A 2002-09-10 2003-09-10 抗菌性ピラゾールカルボン酸ヒドラジド Withdrawn JP2006508178A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40943902P 2002-09-10 2002-09-10
PCT/US2003/028392 WO2004094370A2 (en) 2002-09-10 2003-09-10 Antibacterial pyrazole carboxylic acid hydrazides

Publications (2)

Publication Number Publication Date
JP2006508178A true JP2006508178A (ja) 2006-03-09
JP2006508178A5 JP2006508178A5 (cg-RX-API-DMAC10.html) 2007-09-13

Family

ID=33309471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004571158A Withdrawn JP2006508178A (ja) 2002-09-10 2003-09-10 抗菌性ピラゾールカルボン酸ヒドラジド

Country Status (6)

Country Link
US (1) US20060258729A1 (cg-RX-API-DMAC10.html)
EP (1) EP1549143A2 (cg-RX-API-DMAC10.html)
JP (1) JP2006508178A (cg-RX-API-DMAC10.html)
AU (1) AU2003303953B2 (cg-RX-API-DMAC10.html)
CA (1) CA2497410A1 (cg-RX-API-DMAC10.html)
WO (1) WO2004094370A2 (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013504592A (ja) * 2009-09-11 2013-02-07 グルシンシーシス インコーポレーテッド クロストリジウム・ディフィシル感染症のための選択的抗菌薬

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006017505A2 (en) * 2004-08-04 2006-02-16 Schering Corporation Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
US7786139B2 (en) 2006-11-21 2010-08-31 Omeros Corporation PDE10 inhibitors and related compositions and methods
WO2014059429A2 (en) * 2012-10-12 2014-04-17 Health Research, Inc. Small molecules inhibiting oncoprotein myc
US20240139191A1 (en) * 2020-12-14 2024-05-02 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Small molecules as larp1 ligands
UY39882A (es) * 2021-08-02 2023-06-15 Eurofarma Laboratorios S A COMPUESTOS NACILHIDRAZÓNICOS INHIBIDORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, COMPOSICIONES, USOS, MÉTODOS DE TRATAMIENTO DE ESTOS Y KITS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232685B2 (en) * 2001-12-19 2007-06-19 The Regents Of The Universtiy Of California Cell lines with latent immunodeficiency virus and methods of use thereof
WO2003105840A2 (en) * 2002-06-17 2003-12-24 The Pennsylvania State Research Foundation Sphingosine kinase inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013504592A (ja) * 2009-09-11 2013-02-07 グルシンシーシス インコーポレーテッド クロストリジウム・ディフィシル感染症のための選択的抗菌薬

Also Published As

Publication number Publication date
AU2003303953B2 (en) 2007-10-04
EP1549143A2 (en) 2005-07-06
AU2003303953A1 (en) 2004-11-19
WO2004094370A3 (en) 2005-03-03
WO2004094370A2 (en) 2004-11-04
CA2497410A1 (en) 2004-11-04
US20060258729A1 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
Malaviya et al. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis
RU2609259C2 (ru) Пиримидиновые ингибиторы гиразы и топоизомеразы iv
JP2007502861A (ja) 抗菌方法及び組成物
Stein The 4‐Quinolone Antibiotics: Past, Present, and Future
JP5470245B2 (ja) バイオフィルム形成の処置のためのトリアゾール化合物
US11731946B2 (en) Broad spectrum antivirulence, anti-persistence compounds
Celandroni et al. Antimicrobial activity of Xibornol and a Xibornol-based formulation against gram-positive pathogens of the respiratory tract
US20150273025A1 (en) Apyrase treatments
Boerema et al. Efficacy and safety of ciprofloxacin (Bay 0 9867) in the treatment of patients with complicated urinary tract infections
Koley et al. Genetic basis of biofilm formation and spread of nosocomial infections
US12622919B2 (en) Methods for treating hypervirulent Klebsiella pneumoniae infection
US12016874B2 (en) Methods and compositions for treating carbapenem-resistant klebsiella pneumoniae infections
AU2003303953B2 (en) Antibacterial pyrazole carboxylic acid hydrazides
JP2001526060A (ja) 抗感染症薬としての酵素プロドラッグの適用
JP2022548005A (ja) 操作された細胞及びその使用
US20150087614A1 (en) Methods and compositions for reducing the proliferation of gram positive bacteria
KR102002172B1 (ko) 항병원성 활성 및 바이오필름 형성 억제 효과를 나타내는 화합물의 신규한 용도
US20200147086A1 (en) Inhibitors of nucleotidyltransferase superfamily enzymes as antibiotics
Kosmidis et al. Fleroxacin in single dose oral therapy of uncomplicated lower urinary tract infection
US7595328B2 (en) Methods of use of quinolone compounds against pneumococcal and Haemophilus bacteria
JP2017506240A (ja) 抗菌剤を含む医薬組成物
JP2017507162A (ja) 抗菌薬を含む医薬組成物
KR102198101B1 (ko) 황색포도상구균 및 결핵균에 대한 항균 조성물
CN110215445B (zh) 香草酸在抑制多重耐药霍氏肠杆菌生长中的应用
CN114617886A (zh) 化合物及其药学上可接受的盐的抗菌用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070724

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20080204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080205